vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis
نویسندگان
چکیده
background vulvovaginal candidiasis (vvc) is a fungal infection of the vagina and vulva. it is usually caused by candida albicans, however, occasionally other candida species are responsible. the optimal treatment of vvc has not yet been defined. the present study was designed to compare the efficacy and safety of a single oral dose of fluconazole with clotrimazole vaginal cream as the treatment of choice for recurrent vvc. materials and methods we conducted a clinical trial study on 124 women with rvvc. sampling of vaginal discharge was achieved for clinically suspected patients, then, observed with koh for vaginal candidiasis. sample culture was performed for cases in whom the result of direct examination was negative but there was high clinical suspicion of the disease. for laboratory examination, swab specimens were placed on sabourauds agar plus chloramphenicol and cyclohexamide with natural ph. for treatment, patients were randomized systematically in 2 equal groups, one receiving clotrimazole vaginal cream 5g/day for 7 days for acute episode and 5g twice a week for 6 months as a prophylaxis. the second group was prescribed single oral dose of fluconazole capsule 150 mg for acute episode followed by prophylactic regimen of 150 mg weekly for 6 months. results a total of 124 women with rvvc were enrolled and assigned in 2 groups of fluconazole and clotrimazole with the mean age of 32±5 years (a range, 18-50 years) and 32±2 years (a range, 19-49 years), respectively. of 117 cases, the recurrence rate was 8.6% in fluconazole and 8.5% in clotrimazole group. recurrence rate in follow up period (second 6 months) was 38.3% and 40%, respectively (ns). conclusion response to treatment and reduction in recurrence rate of vvc were similar among fluconazole and longterm users of azole vaginal creams
منابع مشابه
Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis.
OBJECTIVE To compare the safety and efficacy of fluconazole 150 mg single dose and intra-vaginal clotrimazole 200mg per day for six days in the treatment of the acute episode of vulvovaginal candidiasis (VVC). METHODS In a prospective study, 142 patients with acute clinical and mycological confirmed VVC were enrolled and divided randomly in two groups. 70 patients received intra-vaginal table...
متن کاملMiconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis.
AIMS Miconazole is a synthetic imidazole antifungal that has a broad spectrum of activity against Candida albicans and non-albicans Candida species. The aim of this study was to evaluate the efficacy and safety of miconazole nitrate vaginal suppository and oral fluconazole in treating severe vulvovaginal candidiasis (SVVC). METHODS In this prospective, randomized case control study, 577 cases...
متن کاملEfficacy of itraconazole versus fluconazole in vaginal candidiasis.
OBJECTIVE To compare the efficacy of fluconazole 150mg single dose and itraconazole 200mg twice for one day in the treatment of acute vulvovaginal candidiasis. METHODS The study was carried out at the Department of Dermatology, PNS Shifa Hospital, Karachi, from March, 2008 to February 2009 and comprised 60 women with clinical and mycological diagnosis of vaginal candidiasis. Diagnosis was bas...
متن کاملCorrigendum to “Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis”
[This corrects the article DOI: 10.5402/2012/375806.].
متن کاملFactors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis
Vulvovaginal candidiasis (VVC) is an extremely common cause of vaginal symptoms in women. Multiple antifungal products are available by either the oral or vaginal route, although no new drugs have become available for two decades. Given the therapeutic equivalence of the antimycotic agents and their routes of administration, the specific drug and formulation selected is entirely arbitrary in re...
متن کاملSingle-dose sertaconazole vaginal tablet treatment of vulvovaginal candidiasis.
BACKGROUND Vulvovaginal candidiasis (WC) is a bothersome disease in women. Poor compliance with the continuous use of antifungal vaginal drugs often results in treatment failure. The aim of the present study was to evaluate the efficacy, acceptability, and safety of single-dose sertaconazole vaginal tablet (500 mg) treatment compared with conventional 3-dose econazole vaginal tablet (150 mg) tr...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
archives of clinical infectious diseasesجلد ۲، شماره ۱، صفحات ۱۷-۲۲
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023